Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced
Author:
Affiliation:
1. Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea
2. Department of Pediatrics, Korea Hemophilia Foundation Hospital, Seoul, Korea
Publisher
The Editorial Office of Gut and Liver
Subject
Gastroenterology,Hepatology
Link
http://pdf.medrang.co.kr/GNL/2017/011/ekjg011-05-19.pdf
Reference23 articles.
1. Korea hemophilia foundation registry trends 1991-2012: patient registry, demographics, health services utilization
2. Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea
3. Nonzero Risk of Hepatocellular Carcinoma Even after Sustained Virological Response
4. Ledipasvir-sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disorders
5. High Sustained Virologic Response to Daclatasvir Plus Asunaprevir in Elderly and Cirrhotic Patients with Hepatitis C Virus Genotype 1b Without Baseline NS5A Polymorphisms
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management;Journal of Multidisciplinary Healthcare;2022-10
2. Prevalence and risk factors for hepatocellular carcinoma in individuals with haemophilia in the era of direct‐acting antiviral agents: A national inpatient sample study;Haemophilia;2022-06-21
3. Efficacy and Safety of Ombitasvir/Paritaprevir/ Ritonavir + Dasabuvir ± Ribavirin Combinations in Patients with Genotype 1 Hepatitis C and Inherited Bleeding Disorders;Turkish Journal of Gastroenterology;2022-05-26
4. Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia;Journal of Clinical Medicine;2022-03-07
5. Clinical burden of hemophilia in older adults: Beyond bleeding risk;Blood Reviews;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3